RadNet reported a strong fourth quarter with a 17.0% increase in revenue and a 5.5% increase in Adjusted EBITDA compared to the previous year. The company's key metrics improved, including revenue, Adjusted EBITDA, and aggregate and same-center volumes.
Revenue increased by 17.0% compared to Q4 2018.
Adjusted EBITDA increased by 5.5% compared to Q4 2018.
Net income was $10.4 million, or $0.21 per diluted share.
MRI, CT, and PET/CT volumes increased by 6.7%, 9.3%, and 13.6%, respectively.
RadNet is optimistic about its business in 2020, expecting stable Medicare reimbursement, potential upside in rates with private payors, and contributions from recent acquisitions and joint ventures. The company also plans to accelerate its commitment to AI solutions for greater productivity and accuracy.